...
首页> 外文期刊>Inflammation >Protective Effect of 1,25-Dihydroxyvitamin D3 on Lipopolysaccharide-Induced Intestinal Epithelial Tight Junction Injury in Caco-2 Cell Monolayers
【24h】

Protective Effect of 1,25-Dihydroxyvitamin D3 on Lipopolysaccharide-Induced Intestinal Epithelial Tight Junction Injury in Caco-2 Cell Monolayers

机译:1,25-二羟基维生素D3对脂多糖诱导的Caco-2细胞单层肠上皮紧密连接损伤的保护作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Lipopolysaccharide was found to be elevated in the plasma of necrotizing enterocolitis (NEC) and inflammatory bowel disease (IBD) patients and may play an important role in the pathogenesis and propagation of these intestinal diseases. To illustrate the destructive effect of lipopolysaccharide (LPS) and to test the protective effect of 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) on LPS-induced barrier injury, an in vitro intestinal epithelia barrier model was established with Caco-2 monolayers and treated with clinically relevant concentrations (1-10 ng/ml) of LPS with or without 1,25(OH)2D3. Transepithelial electrical resistance (TEER) and FITC-Dextran 40kda (FD-40) flux were measured to reflect monolayer permeability. We found that LPS at clinically relevant concentrations increased intestinal permeability by downregulating and redistributing tight junction (TJ) proteins. 1,25(OH)2D3 added at baseline or at day 4 abrogated the destructive effect of LPS on monolayer permeability by restoring the expression and localization of TJ proteins. LPS, at clinically relevant concentrations, also downregulated the expression of vitamin D receptor (VDR); 1,25 (OH)2D3, however, could restore the expression of VDR. Our findings illustrate the mechanism underlying the destructive effect of clinically relevant concentrations of LPS on intestinal TJ barrier and provide evidence for the clinical application of vitamin D in LPS-related intestinal barrier dysfunction.
机译:发现脂多糖在坏死性小肠结肠炎(NEC)和炎性肠病(IBD)患者的血浆中升高,并且可能在这些肠道疾病的发病和传播中起重要作用。为了说明脂多糖(LPS)的破坏作用并测试1,25-二羟基维生素D3(1,25(OH)2D3)对LPS诱导的屏障损伤的保护作用,使用Caco建立了体外肠上皮屏障模型-2单层,并在有或没有1,25(OH)2D3的情况下用临床相关浓度(1-10 ng / ml)的LPS处理。测量跨上皮电阻(TEER)和FITC-Dextran 40kda(FD-40)通量以反映单层渗透率。我们发现,在临床上相关浓度的LPS通过下调和重新分布紧密连接(TJ)蛋白来增加肠道通透性。在基线或第4天添加1,25(OH)2D3,可通过恢复TJ蛋白的表达和定位来消除LPS对单层渗透性的破坏作用。具有临床相关浓度的LPS也下调了维生素D受体(VDR)的表达; 1,25(OH)2D3,但是,可以恢复VDR的表达。我们的发现说明了临床相关浓度的LPS对肠TJ屏障具有破坏作用的潜在机理,并为维生素D在LPS相关的肠屏障功能障碍中的临床应用提供了证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号